DHRM [Dehaier Medical Systems] 8-K: Dehaier Medical Appoints Interim Chief Financial Officer BEIJING,

[Dehaier Medical Appoints Interim Chief Financial Officer BEIJING, Sept. 30, 2011 /PRNewswire-Asia-FirstCall/ — Dehaier Medical (NASDAQ: DHRM) an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that Aileen Qi has been appointed interim Chief Financial Officer, effective October 1, 2011. Ms. Rita Liu has tendered her resignation as] [ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. Item 5.02(b) Ms. Rita Liu has tendered her resignation as the Chief Financial Officer of Dehaier Medical Systems Limited (the “Company”), effective September 30, 2011. Ms. Liu resigned in order to pursue other professional opportunities, and not due to any]

DHRM [Dehaier Medical Systems] 8-K: (Original Filing)

[FORM 8-K CURRENT REPORT Date of report (date of earliest event reported): August 25, 2011 DEHAIER MEDICAL SYSTEMS LIMITED British Virgin Islands 001-34661 Not Applicable (State or Other Jurisdiction of Incorporation) (IRS Employer Identification No.) Room 908, East Plaza th No. 15 West 4 Haidian District, Beijing People’s Republic of China 100195 ¨ ¨ ¨ ¨ ITEM 5.07 SUBMISSION OF]

DHRM [Dehaier Medical Systems] 8-K: FORM 8-K CURRENT REPORT Date of report (date

[FORM 8-K CURRENT REPORT Date of report (date of earliest event reported): August 25, 2011 DEHAIER MEDICAL SYSTEMS LIMITED British Virgin Islands 001-34661 Not Applicable (State or Other Jurisdiction of Incorporation) (IRS Employer Identification No.) Room 908, East Plaza th No. 15 West 4 Haidian District, Beijing People’s Republic of China 100195 ¨ ¨ ¨ ¨ ITEM 5.07 SUBMISSION OF]

DHRM [Dehaier Medical Systems] 10-Q: (Original Filing)

[FORM 10-Q x For the three and six month periods ended June 30, 2011 ¨ For the transition period from Dehaier Medical Systems Limited British Virgin Islands Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification number) Room 908, East Plaza No. 15 West 4th Ring North Road Haidian District, Beijing, 100195 People’s Republic of China] [I, Ping Chen, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [I, Zheng (Rita) Liu, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Ping Chen EX-32.1 4 v230949_ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Zheng (Rita) Liu Chief Financial Officer (Principal Financial Officer) EX-32.2 5 v230949_ex32-2.htm]

DHRM [Dehaier Medical Systems] 10-Q: FORM 10-Q x For the three and six

[FORM 10-Q x For the three and six month periods ended June 30, 2011 ¨ For the transition period from Dehaier Medical Systems Limited British Virgin Islands Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification number) Room 908, East Plaza No. 15 West 4th Ring North Road Haidian District, Beijing, 100195 People’s Republic of China] [I, Ping Chen, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [I, Zheng (Rita) Liu, certify that: (1) I have reviewed this Form 10-Q of Dehaier Medical Systems Limited; (2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Ping Chen EX-32.1 4 v230949_ex32-1.htm] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the this period report fairly presents, in all material respects, the financial condition and results of operations of Dehaier Medical Systems Limited. Zheng (Rita) Liu Chief Financial Officer (Principal Financial Officer) EX-32.2 5 v230949_ex32-2.htm]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Second Quarter 2011 Financial Results Shenzhen, China – August 8, 2011 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2011. Highlights for Second Quarter 2011 • Net revenues were $217.3 million, an increase of 21.2%]

MR [Mindray Medical International] 6-K: Mindray Announces Second Quarter 2011 Financial Results Shenzhen,

[Mindray Announces Second Quarter 2011 Financial Results Shenzhen, China – August 8, 2011 – Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June 30, 2011. Highlights for Second Quarter 2011 • Net revenues were $217.3 million, an increase of 21.2%]

MR [Mindray Medical International] SC 13G: (Original Filing)

[The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed but]

MR [Mindray Medical International] SC 13G: The remainder of this cover page shall be

[The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed but]

MR [Mindray Medical International] 6-K: (Original Filing)

[Mindray Announces Second Quarter 2011 Financial Results STYLE="font-family:Times New Roman" SIZE="2"> Shenzhen, China August8, 2011 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the second quarter ended June30, 2011. Highlights for Second Quarter 2011 Net revenues were $217.3 million,]

Skip to toolbar